Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates

NCT00231348 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00231348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00231348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nefazodone in the Treatment of Social Phobia: Functional Brain Imaging and Neuroendocrine Correlates
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
April 30, 2000
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder (sad)